|
PTPRK expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 3.18839954438488E-10 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
2.6077000003788E-07 |
| Normal-vs-Stage2 |
3.918800E-03 |
| Normal-vs-Stage3 |
3.402500E-03 |
| Normal-vs-Stage4 |
1.551400E-01 |
| Stage1-vs-Stage2 |
7.134600E-01 |
| Stage1-vs-Stage3 |
6.897800E-01 |
| Stage1-vs-Stage4 |
6.911800E-01 |
| Stage2-vs-Stage3 |
9.926800E-01 |
| Stage2-vs-Stage4 |
5.386400E-01 |
| Stage3-vs-Stage4 |
5.720200E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
1.87789994665621E-09 |
| Normal-vs-AfricanAmerican |
3.33730000001697E-06 |
| Normal-vs-Asian |
8.831000E-01 |
| Caucasian-vs-AfricanAmerican |
6.669800E-01 |
| Caucasian-vs-Asian |
1.261810E-01 |
| AfricanAmerican-vs-Asian |
7.000000E-02 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
1.54449999456574E-08 |
| Normal-vs-Female |
5.69160000241098E-08 |
| Male-vs-Female |
1.506960E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
2.880900E-03 |
| Normal-vs-Extreme_Weight |
1.202820E-03 |
| Normal-vs-Obese |
1.75609999986115E-07 |
| Normal-vs-Extreme_Obese |
1.065600E-01 |
| Normal_Weight-vs-Extreme_Weight |
9.476000E-01 |
| Normal_Weight-vs-Obese |
2.108000E-02 |
| Normal_Weight-vs-Extreme_Obese |
6.618600E-01 |
| Extreme_Weight-vs-Obese |
1.055550E-02 |
| Extreme_Weight-vs-Extreme_Obese |
6.600800E-01 |
| Obese-vs-Extreme_Obese |
4.040000E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
1.367710E-02 |
| Normal-vs-Age(41-60Yrs) |
3.16810022660263E-10 |
| Normal-vs-Age(61-80Yrs) |
2.05119999996395E-06 |
| Normal-vs-Age(81-100Yrs) |
1.987180E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
5.407000E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
8.691200E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
2.503600E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
1.183410E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
7.822100E-02 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
3.496200E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
1.51110013391076E-10 |
| Normal-VS-Type2 PRCC |
2.444200E-04 |
| Normal-VS-KIRP CIMP |
3.364200E-02 |
| Normal-VS-Unclassified PRCC |
3.816700E-03 |
| Type1 PRCC-VS-Type2 PRCC |
2.154400E-01 |
| Type1 PRCC-VS-KIRP CIMP |
7.104000E-01 |
| Type1 PRCC-VS-Unclassified PRCC |
7.004000E-01 |
| Type2 PRCC-VS-KIRP CIMP |
8.579600E-01 |
| Type2 PRCC-VS-Unclassified PRCC |
6.387200E-01 |
| KIRP CIMP-VS-Unclassified PRCC |
9.082600E-01 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
9.279000E-03 |
| Normal-vs-N1 |
4.541400E-03 |
| Normal-vs-N2 |
2.516500E-02 |
| N0-vs-N1 |
9.272000E-02 |
| N0-vs-N2 |
7.440400E-01 |
| N1-vs-N2 |
5.908600E-01 |
|
|
